Get access

Restless legs syndrome due to interferon-α



A patient developed restless legs symptoms paralleling the course of interferon-α (IFNα) therapy for chronic hepatitis C. Symptoms began during a course of IFNα, resolved with its suspension, and recurred on rechallenge. Restless legs syndrome may thus be an adverse effect of IFNα treatment. © 2004 Movement Disorder Society

Get access to the full text of this article